Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 4
2008 3
2009 3
2010 2
2011 7
2012 3
2013 8
2014 9
2015 9
2016 6
2017 7
2018 8
2019 19
2020 16
2021 13
2022 11
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Biodiversity: the overlooked source of human health.
Linhares Y, Kaganski A, Agyare C, Kurnaz IA, Neergheen V, Kolodziejczyk B, Kędra M, Wahajuddin M, El-Youssf L, Dela Cruz TE, Baran Y, Pešić M, Shrestha U, Bakiu R, Allard PM, Rybtsov S, Pieri M, Siciliano V, Flores Bueso Y. Linhares Y, et al. Among authors: pesic m. Trends Mol Med. 2023 Mar;29(3):173-187. doi: 10.1016/j.molmed.2022.12.002. Epub 2022 Dec 28. Trends Mol Med. 2023. PMID: 36585352 Review.
Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders.
Trajković J, Makevic V, Pesic M, Pavković-Lučić S, Milojevic S, Cvjetkovic S, Hagerman R, Budimirovic DB, Protic D. Trajković J, et al. Among authors: pesic m. Genes (Basel). 2022 Dec 28;14(1):87. doi: 10.3390/genes14010087. Genes (Basel). 2022. PMID: 36672829 Free PMC article. Review.
Advanced technological tools to study multidrug resistance in cancer.
Andrei L, Kasas S, Ochoa Garrido I, Stanković T, Suárez Korsnes M, Vaclavikova R, Assaraf YG, Pešić M. Andrei L, et al. Among authors: pesic m. Drug Resist Updat. 2020 Jan;48:100658. doi: 10.1016/j.drup.2019.100658. Epub 2019 Oct 17. Drug Resist Updat. 2020. PMID: 31678863 Review.
124 results